|
Ascendis Pharma Sponsored ADR
(ASND)
|
13.0 |
$1.0B |
|
5.1M |
198.81 |
|
United Therapeutics Corp Common
(UTHR)
|
11.9 |
$932M |
|
2.2M |
419.21 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
10.8 |
$841M |
|
1.8M |
458.66 |
|
Argenx Se Sponsored ADR
(ARGX)
|
9.3 |
$730M |
|
990k |
737.56 |
|
Krystal Biotech Common
(KRYS)
|
6.3 |
$490M |
|
2.8M |
176.53 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
4.8 |
$376M |
|
11M |
34.49 |
|
Kymera Therapeutics Common
(KYMR)
|
4.6 |
$359M |
|
6.4M |
56.60 |
|
Merus N V Common
(MRUS)
|
4.3 |
$334M |
|
3.5M |
94.15 |
|
Avidity Biosciences Common
(RNA)
|
4.3 |
$333M |
|
7.6M |
43.57 |
|
Apellis Pharmaceuticals Common
(APLS)
|
3.5 |
$277M |
|
12M |
22.63 |
|
Centessa Pharmaceuticals Sponsored Adr
(CNTA)
|
3.4 |
$262M |
|
11M |
24.25 |
|
Uniqure Nv Common
(QURE)
|
3.3 |
$259M |
|
4.4M |
58.37 |
|
Xenon Pharmaceuticals Common
(XENE)
|
2.8 |
$217M |
|
5.4M |
40.15 |
|
Akero Therapeutics Common
(AKRO)
|
2.4 |
$188M |
|
4.0M |
47.48 |
|
Vera Therapeutics Common
(VERA)
|
2.3 |
$181M |
|
6.2M |
29.06 |
|
Soleno Therapeutics Common
(SLNO)
|
2.2 |
$174M |
|
2.6M |
67.60 |
|
Structure Therapeutics Sponsored Ads
(GPCR)
|
1.9 |
$151M |
|
5.4M |
28.00 |
|
Tourmaline Bio Common
(TRML)
|
1.6 |
$122M |
|
2.6M |
47.83 |
|
Ocular Therapeutix Common
(OCUL)
|
1.5 |
$120M |
|
10M |
11.69 |
|
Amicus Therapeutics Common
(FOLD)
|
1.5 |
$118M |
|
15M |
7.88 |
|
89bio Common
(ETNB)
|
1.2 |
$94M |
|
6.4M |
14.70 |
|
Taysha Gene Therapies Common
(TSHA)
|
0.9 |
$71M |
|
22M |
3.27 |
|
Alkermes Common
(ALKS)
|
0.9 |
$67M |
|
2.2M |
30.00 |
|
Oruka Therapeutics Common
(ORKA)
|
0.3 |
$26M |
|
1.3M |
19.23 |
|
Septerna Common
(SEPN)
|
0.3 |
$25M |
|
1.3M |
18.81 |
|
Mannkind Corp Common
(MNKD)
|
0.3 |
$24M |
|
4.5M |
5.37 |
|
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
0.2 |
$14M |
|
2.0M |
7.17 |
|
Biocryst Pharmaceuticals Common
(BCRX)
|
0.1 |
$9.5M |
|
1.3M |
7.59 |
|
Whitehawk Therapeutics Common
(WHWK)
|
0.1 |
$5.4M |
|
2.8M |
1.90 |
|
Tango Therapeutics Common
(TNGX)
|
0.1 |
$4.6M |
|
545k |
8.40 |